According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ15.15. In 2022 the company made an earnings per share (EPS) of -ยฃ14.00 a decrease over its 2021 EPS that were of -ยฃ11.87.